Intrinsic vascular dopamine - a key modulator of hypoxia-induced vasodilatation in splanchnic vessels

Journal of Physiology

Volumn 592, Issue 8, 2014, Pages 1745-1756

  Pfeil, Uwe ^a   Kuncova, Jitka ^b   Brüggmann, Doerthe ^a   Paddenberg, Renate ^a   Rafiq, Amir ^a   Henrich, Michael ^a   Weigand, Markus A ^a   Schlüter, Klaus Dieter ^a   Mewe, Marco ^c   Middendorff, Ralf ^a   Slavikova, Jana ^b   Kummer, Wolfgang ^a,d  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b CHARLES UNIVERSITY   (Czech Republic)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d DZL UGMLC   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AROMATIC LEVO AMINO ACID DECARBOXYLASE; CYCLIC AMP; DOPAMINE; DOPAMINE BETA MONOOXYGENASE; MESSENGER RNA; NORADRENALIN; TYROSINE 3 MONOOXYGENASE; DOPAMINE RECEPTOR BLOCKING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINE RELEASE; ENDOTHELIUM CELL; HYPOXIA; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; SUPERIOR MESENTERIC ARTERY; ANIMAL; CELL CULTURE; CELL HYPOXIA; CYTOLOGY; DRUG EFFECTS; GENETICS; MESENTERIC ARTERY; METABOLISM; PHYSIOLOGY; VASODILATATION; WISTAR RAT;

ANIMALS; AORTA; AROMATIC-L-AMINO-ACID DECARBOXYLASES; CELL HYPOXIA; CELLS, CULTURED; CYCLIC AMP; DOPAMINE; DOPAMINE ANTAGONISTS; DOPAMINE BETA-HYDROXYLASE; ENDOTHELIAL CELLS; MESENTERIC ARTERIES; NOREPINEPHRINE; RATS; RATS, WISTAR; TYROSINE 3-MONOOXYGENASE; VASODILATION;

EID: 84898543560     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2013.262626     Document Type: Article

References (44)

1. 3H]dopamine in the rabbit celiac artery. Eur J Pharmacol 88, 251-254.
2. Basu S, Nagy JA, Pal S, Vasile E, Eckelhoefer IA, Bliss VS, Manseau EJ, Dasgupta PS, Dvorak HF & Mukhopadhyay D (2001). The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor. Nat Med 7, 569-574.
3. Bell C & Lang WJ (1979). Evidence for dopaminergic vasodilator innervation of the canine paw pad. Br J Pharmacol 67, 337-343.
4. Berger SP, Hünger M, Yard BA, Schnuelle P & van der Woude FJ (2000). Dopamine induces the expression of heme oxygenase-1 by human endothelial cells in vitro. Kidney Int 58, 2314-2319.
5. Brain SD & Grant AD (2004). Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev 84, 903-934.
6. Bruce J, Taggart M & Austin C (2004). Contractile responses of isolated rat mesenteric arteries to acute episodes of severe hypoxia and subsequent reoxygenation. Microvasc Res 68, 303-312.
7. Burke AP & Virmani R (2007). Pathophysiology of acute myocardial infarction. Med Clin North Am 91, 553-572.
8. Di Marco GS, Vio CP, Dos Santos OF, Schor N & Casarini DE (2007). Catecholamine production along the nephron. Cell Physiol Biochem 20, 919-924.
9. Dunnett SB, Bentivoglio M, Björklund A & Hökfelt T (eds) (2005). Dopamine. In Handbook of Chemical Neuroanatomy, vol. 21, pp. 1-588. Elsevier, Amsterdam, Netherlands.
10. Edmondson DE, Mattevi A, Binda C, Li M & Hubalek F (2004). Structure and mechanism of monoamine oxidase. Curr Med Chem 11, 1983-1993.
11. Galvin GB & Szabo S (1990). Dopamine in gastrointestinal disease. Dig Dis Sci 35, 1153-1161.
12. Goldstein DS & Holmes C (2008). Neuronal source of plasma dopamine. Clin Chem 54, 1864-1871.
13. Gupte SA, Zias EA, Sarabu MR & Wolin MS (2004). Role of prostaglandins in mediating differences in human internal mammary and radial artery relaxation elicited by hypoxia. J Pharmacol Exp Ther 311, 510-518.
14. Hartman DS & Lanau F (1997). Diversity of dopamine receptors: new molecular and pharmacological developments. Pol J Pharmacol 49, 191-199.
15. Hermsteiner M, Zoltan DR, Doetsch J, Rascher W & Kuenzel W (1999). Human chorionic gonadotropin dilates uterine and mesenteric resistance arteries in pregnant and nonpregnant rats. Pflügers Arch 439, 186-194.
16. Hilditch A, Drew GM & Naylor RJ (1984). SCH 23390 is a very potent and selective antagonist at vascular dopamine receptors. Eur J Pharmacol 97, 333-334.
17. Huemer KH, Garhofer G, Zawinka C, Golestani E, Litschauer B, Schmetterer L & Dorner GT (2003). Effects of dopamine on human retinal vessel diameter and its modulation during flicker stimulation. Am J Physiol Heart Circ Physiol 284, H358-H363.
18. Hui AS, Striet JB, Gudelsky G, Soukhova GK, Gozal E, Beitner-Johnson D, Guo SZ, Sachleben LR Jr, Haycock JW, Gozal D & Czyzyk-Krzeska MF (2003). Regulation of catecholamines by sustained and intermittent hypoxia in neuroendocrine cells and sympathetic neurons. Hypertension 42, 1130-1136.
19. Iijima T & Wasano T (1980). Further studies on catecholamine-containing specific endothelial granules in carp cerebral veins. A fluorescence histochemical and electron microscopy study. Anat Rec 198, 415-420.
20. Kawazoe T, Tsuge H, Imagawa T, Aki K, Kuramitsu S & Fukui K (2007). Structural basis of d-DOPA oxidation by d-amino acid oxidase: alternative pathway for dopamine biosynthesis. Biochem Biophys Res Commun 355, 385-391.
21. Kummer W & Neuhuber WL (1989). Vagal paraganglia of the rat. J Electron Microsc Tech 12, 343-355.
22. Kvetnansky R, Ucropec J, Laukova M, Manz B, Pacak K & Vargovic P (2012). Stress stimulates production of catecholamines in rat adipocytes. Cell Mol Neurobiolol 32, 801-813.
23. Lewis-Tuffin LJ, Quinn PG & Chikaraishi DM (2004). Tyrosine hydroxylase transcription depends primarily on cAMP response element activity, regardless of the type of inducing stimulus. Mol Cell Neurosci 25, 536-547.
24. Lundberg JO & Weitzberg E (2005). NO generation from nitrite and its role in vascular control. Arterioscler Thromb Vasc Biol 25, 915-922.
25. Mezey E, Eisenhofer G, Hansson S, Harta G, Hoffman BJ, Gallatz K, Palkovits M & Hunyady B (1999). Non-neuronal dopamine in the gastrointestinal system. Clin Exp Pharmacol Physiol Suppl 26, S14-22.
26. Mignini F, Traini E, Tomassoni D & Amenta F (2006). Dopamine plasma membrane transporter (DAT) in rat thymus and spleen: an immunochemical and immunohistochemical study. Auton Autacoid Pharmacol 26, 183-189.
27. Otter D & Austin C (1999). Mechanisms of hypoxic vasodilatation of isolated rat mesenteric arteries: a comparison with metabolic inhibition. J Physiol 516, 249-259.
28. Pacheco R, Prado CE, Barrientos MJ & Bernales S (2009). Role of dopamine in the physiology of T-cells and dendritic cells. J Neuroimmunol 216, 8-19.
29. Pfeil U, Paddenberg R & Kummer W (2006). Mitochondrial regulation of hypoxia-induced increase of adrenomedullin mRNA in HL-1 cells. Biochem Biophys Res Commun 343, 885-892.
30. Saeed SA, Shad KF, Saleem T, Javed F & Khan MU (2007). Some new prospects in the understanding of the molecular basis of the pathogenesis of stroke. Exp Brain Res 182, 1-10.
31. Shepperson NB, Duval N & Langer SZ (1982). Dopamine decreases mesenteric blood flow in the anaesthetised dog through the stimulation of postsynaptic alpha 2-adrenoceptors. Eur J Pharmacol 81, 627-635.
32. Shyrock JC & Belardinelli L (1997). Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am J Cardiol 79, 2-10.
33. Slitt AL, Cherrington NJ, Hartley DP, Leazer TM & Klaassen CD (2002). Tissue distribution and renal developmental changes in rat organic cation transporter mRNA levels. Drug Metab Dispos 30, 212-219.
34. Sorriento D, Santulli G, del Guidice C, Anastasio A, Trimarco B & Iaccarino G (2012). Endothelial cells are able to synthesize and release catecholamines both in vitro and in vivo. Hypertension 60, 129-136.
35. Suttner SW & Boldt J (2004). Natriuretic peptide system: physiology and clinical utility. Curr Opin Crit Care 10, 336-341.
36. Toda N (1983). Dopamine vasodilates human cerebral artery. Experientia 39, 1131-1132.
37. Villanueva I, Pinon M, Quevedo-Corona L, Martinez-Olivaras R & Racotta R (2003). Epinephrine and dopamine colocalization with norepinephrine in various peripheral tissues. Life Sci 73, 1645-1653.
38. Weiss B & Rossi GV (1963). Catecholamines, biosynthesis, and inhibitors of formation. Am J Pharm Sci Support Public Health 135, 206-218.
39. Westwood NN, Scarcella DL & Bryan-Lluka LJ (1996). Evidence for uptake1-mediated efflux of catecholamines from pulmonary endothelial cells of perfused lungs of rats. Naunyn Schmiedebergs Arch Pharmacol 353, 528-535.
40. Yamauchi M, Kobayashi Y, Shimoura K, Hattori K & Nakase A (1992). Endothelium-dependent and -independent relaxation by dopamine in the rabbit pulmonary artery. Clin Exp Pharmacol Physiol 19, 401-410.
41. Yuan XJ, Tod ML, Rubin LJ & Blaustein MP (1990). Contrasting effects of hypoxia on tension in rat pulmonary and mesenteric arteries. Am J Physiol Heart Circ Physiol 259, H281-H289.
42. Zarei S, Frieden M, Rubi B, Villemin P, Gauthier BR, Maechler P & Vischer UM (2006). Dopamine modulates von Willebrand factor secretion in endothelial cells via D2-D4 receptors. J Thromb Haemost 4, 1588-1595.
43. Zeng C, Wang D, Yang Z, Wang Z, Asico LD & Wilcox CS (2004). Dopamine D1 receptor augmentation of D3 receptor action in rat aortic or mesenteric vascular smooth muscles. Hypertension 43, 673-679.
44. Zeng C, Zhang M, Asico LD, Eisner GM & Jose PA (2007). The dopaminergic system in hypertension. Clin Sci 112, 583-597.